ATE386797T1 - Vibrio cholerae impfstoffkandidaten und verfahren zu deren herstellung - Google Patents

Vibrio cholerae impfstoffkandidaten und verfahren zu deren herstellung

Info

Publication number
ATE386797T1
ATE386797T1 AT98964347T AT98964347T ATE386797T1 AT E386797 T1 ATE386797 T1 AT E386797T1 AT 98964347 T AT98964347 T AT 98964347T AT 98964347 T AT98964347 T AT 98964347T AT E386797 T1 ATE386797 T1 AT E386797T1
Authority
AT
Austria
Prior art keywords
vibrio cholerae
production
vaccine candidates
cholerae vaccine
thya
Prior art date
Application number
AT98964347T
Other languages
English (en)
Inventor
Gomez Javier Campos
Calzada Rafael Alfredo Fando
Gonzalez Boris Luis Rodriguez
Perez Talena Yamile Ledon
Diaz Edgar Valle
Cabrera Anisia Juana Silva
Robles Jorge Antonio Benitez
Original Assignee
Cnic Ct Nac Investigaciones
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cnic Ct Nac Investigaciones filed Critical Cnic Ct Nac Investigaciones
Application granted granted Critical
Publication of ATE386797T1 publication Critical patent/ATE386797T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AT98964347T 1997-12-30 1998-12-30 Vibrio cholerae impfstoffkandidaten und verfahren zu deren herstellung ATE386797T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1997142A CU22661A1 (es) 1997-12-30 1997-12-30 Nuevos candidatos vacunales de vibrio cholerae y método de obtención

Publications (1)

Publication Number Publication Date
ATE386797T1 true ATE386797T1 (de) 2008-03-15

Family

ID=5459446

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98964347T ATE386797T1 (de) 1997-12-30 1998-12-30 Vibrio cholerae impfstoffkandidaten und verfahren zu deren herstellung

Country Status (12)

Country Link
US (1) US6723323B1 (de)
EP (1) EP1099759B1 (de)
JP (1) JP2002500047A (de)
CN (1) CN100372936C (de)
AT (1) ATE386797T1 (de)
AU (1) AU1959199A (de)
BR (1) BR9814600A (de)
CU (1) CU22661A1 (de)
DE (1) DE69839161T2 (de)
DK (1) DK1099759T3 (de)
ES (1) ES2303727T3 (de)
WO (1) WO1999035271A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801852D0 (sv) * 1998-05-26 1998-05-26 Sbl Vaccin Ab Method of producing thy A-strains of Vibro cholerae, suck strains and their use
AU2000278267A1 (en) * 2000-09-01 2002-03-22 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Vibrio cholerae o139 conjugate vaccines
GB0325494D0 (en) * 2003-10-31 2003-12-03 Sbl Vaccin Ab Expression system
US20060003454A1 (en) * 2004-07-02 2006-01-05 Conjugon, Inc. Non-dividing donor cells for gene transfer
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
MY190074A (en) * 2018-01-09 2022-03-24 Aimst Univ A monovalent vaccine formulation and a method for preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1017726A1 (ru) * 1981-09-07 1983-05-15 Ростовский-На-Дону Государственный Научно-Исследовательский Противочумный Институт Штамм @ @ @ 673/67 @ используемый в качестве тест-культуры дл определени тимидина в питательных средах
EP0251579A3 (de) * 1986-06-24 1989-03-22 Enterovax Research Pty. Ltd. Markiersystem ohne Antibiotika
GB9007194D0 (en) * 1990-03-30 1990-05-30 Wellcome Found Live vaccines
JPH0630766A (ja) * 1992-07-15 1994-02-08 Res Dev Corp Of Japan 弱毒化された安全性の高い赤痢生ワクチン
DE69434951D1 (de) * 1993-02-22 2007-05-24 Gen Hospital Corp Heterologe antigene in stämmen zur impfung mit lebendzellen
US5434065A (en) * 1993-05-06 1995-07-18 President And Fellows Of Harvard College In vivo selection of microbial virulence genes
WO1995018633A1 (en) * 1994-01-06 1995-07-13 President And Fellows Of Harvard College Soft agar penetration-defective mutants
CA2231332C (en) * 1995-09-06 2007-04-17 Arthur A. Branstrom Bacterial delivery system
SE9801852D0 (sv) * 1998-05-26 1998-05-26 Sbl Vaccin Ab Method of producing thy A-strains of Vibro cholerae, suck strains and their use

Also Published As

Publication number Publication date
WO1999035271A2 (es) 1999-07-15
EP1099759B1 (de) 2008-02-20
ES2303727T3 (es) 2008-08-16
CU22661A1 (es) 2001-04-27
CN100372936C (zh) 2008-03-05
CN1301301A (zh) 2001-06-27
WO1999035271A3 (es) 1999-11-25
DK1099759T3 (da) 2008-06-23
DE69839161T2 (de) 2009-03-26
DE69839161D1 (de) 2008-04-03
EP1099759A2 (de) 2001-05-16
AU1959199A (en) 1999-07-26
US6723323B1 (en) 2004-04-20
JP2002500047A (ja) 2002-01-08
BR9814600A (pt) 2002-02-19

Similar Documents

Publication Publication Date Title
ATE198355T1 (de) Alpha-amidierende enzymzusammensetzungen und verfahren zu deren herstellung und verwendung
DE69231745D1 (de) Gensequenzen kodierend für Flavonoid-Stoffwechselwegenzyme und deren Verwendung
EP1020528A3 (de) Verfahren zur Hestellung von ausgeschiedene Proteine
SG152917A1 (en) Neisseria meningitidis antigens
WO2000049158A3 (en) Psa and klk-2 splicing variants
ATE386797T1 (de) Vibrio cholerae impfstoffkandidaten und verfahren zu deren herstellung
WO1998044104A3 (de) Flip-gen und flip-protein
ATE346931T1 (de) Clostridium perfringens impfstoff
DE69739107D1 (de) Hefevektoren und verfahren für ihre benutzung für die produktion von proteinen.
ES2123641T3 (es) Secuencias de acidos nucleicos que codifican o que son complementarias a secuencias de acidos nucleicos que codifican para el receptor de la interleucina 9.
DK0776971T3 (da) Hyperthermostabilt proteasegen
AR010362A1 (es) UN GEN QUIMÉRICO, UN MICROORGANISMO MODIFICADO TRANSFORMADO CON EL GEN QUIMÉRICO, UN PLÁSMIDO, UN MICROORGANISMO MODIFICADO TRANSFORMADO CON EL PLÁSMIDO, MÉTODO DE MODIFICACION METABOLOLICA, MÉTODO DE PRODUCCIoN DE UNA PROTEíNA DE RAFINOSA SINTASA AISLADA Y UN ANTICUERPO ANTI-RAFINOSA SINTETASA.
DE3485923D1 (de) Dna-gen, verfahren zu seiner herstellung und dieses gen enthaltendes plasmid.
WO2000070016A3 (en) Genetically modified plants tolerant of stress conditions
ATE199397T1 (de) Multiple virus-resistenz aufweisende transgene pflanzen und verfahren zu ihrer herstellung
DE59509667D1 (de) Vakzine zur Immunisierung gegen TBE-Virusinfektionen sowie ein Verfahren zu dessen Herstellung
ATE329020T1 (de) Verfahren zur klonierung von genen
WO2000056932A3 (en) Germline-competent avian cells
CO4440441A1 (es) Enzima dextranasa, metodo para su produccion y adn que la codifica
DK1123396T3 (da) Minimale promotorer og anvendelser deraf
KR920004577A (ko) 단백질 합성의 cks 방법
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
PT983366E (pt) Adn que codifica uma sintetase de quitina de artropode
DE59510916D1 (de) Verbessertes, induktionsfreies Verfahren zur Gentechnischen Herstellung von Glutarylamidase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1099759

Country of ref document: EP